Find uplifting stories about heroes, innovations, and solutions
17 results for "car-t therapy"
A revolutionary cancer treatment just gave a Philadelphia man his third kidney transplant by removing the antibodies that kept rejecting donors. Penn Medicine's breakthrough trial could open transplants to thousands of patients currently deemed "impossible to match."
Mount Sinai researchers discovered that focused radiation helps CAR-T therapy work better against tough-to-treat solid tumors like lung cancer and melanoma. The breakthrough could make this life-saving treatment safer and more effective for thousands of cancer patients.
A world-first clinical trial suggests that specially enriched immune cells could fight cancer more effectively and with fewer side effects than standard treatments. Five of 11 patients with hard-to-treat blood cancers entered full remission using this new approach.
A groundbreaking cell therapy has successfully treated stiff person syndrome, a rare neurological disorder that causes severe muscle stiffness and mobility problems. If approved by the FDA this summer, it would become the first treatment for the condition and the first personalized CAR-T therapy for any autoimmune disease.
Twenty people with smoldering multiple myeloma have zero detectable cancer cells after receiving an aggressive immunotherapy treatment. The results are so complete that researchers are cautiously using a word they usually avoid: cure.
A therapy originally designed to fight blood cancer is giving hope to people with severe autoimmune diseases who've run out of options. Early results show some patients are achieving years of remission after just one treatment.
A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients. The treatment could prevent cancer recurrence in high-risk patients for the first time.
The FDA just approved testing of a revolutionary therapy that could cure lupus, rheumatoid arthritis, and other autoimmune diseases without harsh chemotherapy. The breakthrough could help 15 million Americans escape lifelong medications.
A German woman who spent weeks bedridden with three life-threatening autoimmune diseases is now symptom-free after a single treatment with engineered immune cells. She hasn't needed medication since receiving the therapy that doctors called her "last chance."
A young woman dying from lupus became the first autoimmune patient treated with CAR-T cell therapy five years ago. She's now in complete remission and working at the very clinic where doctors saved her life.
A groundbreaking immune cell therapy caused aggressive brain tumors to shrink dramatically within days in early trials. The treatment offers new hope for glioblastoma, one of the deadliest cancers with few effective options.
When Alex's blood cancer returned for the third time, doctors in his home country said there was nothing more they could do. A desperate global search led him to Beijing, where cutting-edge treatment gave him a second chance at life. #
Researchers have developed a method to engineer cancer-fighting immune cells directly in the bloodstream, eliminating the need for expensive lab processing. Early tests show tumors disappearing in two weeks.
Scientists just cleared tumors in mice by creating cancer-fighting cells directly inside their bodies, skipping the costly lab process. This breakthrough could make one of medicine's most powerful cancer treatments faster and more accessible.
Scientists just cleared tumors in mice without removing their cells from their bodies first. This breakthrough could transform how we fight cancer.
Cancer specialists just published the first comprehensive guide to help patients thrive years after groundbreaking CAR-T cell therapy. The new roadmap tackles a crucial gap as more blood cancer patients survive longer than ever before.
A startup is bringing hope to glioblastoma patients with an experimental CAR-T therapy that made all three initial patients' tumors shrink dramatically. One patient remains cancer-free more than 2.5 years after treatment.